Rigel Pharmaceuticals (RIGL) PT Raised to $7 at Cantor Fitzgerald, Following Strategic Business Update

February 18, 2021 2:54 PM EST
Get Alerts RIGL Hot Sheet
Price: $3.58 -5.29%

Rating Summary:
    7 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Cantor Fitzgerald analyst Kristen Kluska raised the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $7.00 (from $5.00) while maintaining a Overweight rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Cantor Fitzgerald